Parvovirus B19 infection in a patient with common variable immunodeficiency Parvovirus B19 infection in a patient with common variable immunodeficiency

Main Article Content

Magda Zanelli
Loredana Reggiani
Francesca Sanguedolce
Maurizio Zizzo
Giovanni Martino
Angelo Genua
Stefano Ascani

Keywords

Parvovirus B19, Immunodeficiency, Bone marrow, Megaloblasts

Abstract

n/a

Downloads

Download data is not yet available.
Abstract 481 | PDF Downloads 97 HTML Downloads 47

References

1. Urio F, George H, Tluway F, Nyambo TB, Mmbando BP, Makani J. Prevalence and Factors Associated with Human Parvovirus B19 Infection in Sickle Cell Patients Hospitalized in Tanzania. Mediterr J Hematol Infect Dis. 2019;11(1):e2019054.
2. Peterlana D.; Puccetti A.; Corrocher R.; Lunardi C. Serologic and molecular detection of human Parvovirus B19 infection. Clin Chim Acta 2006, 372, 14-23.
3. Heegaard H.D.; Brown K.E. Human parvovirus B19. Clin Microbiol Rev 2002, 15, 485-505.
4. Adams S.T.M.; Schmidt K.M.; Cost M.K.; Marshall G.S. Common variable immunodeficiency presenting with persistent parvovirus B19 infection. Pediatrics 2012, 130, e1711-5.
5. Ruiz Gutiérrez L.; Albarrán F.; Moruno H.; Cuende E. Parvovirus B19 chronic monoarthritis in a patient with common variable immunodeficiency. Reumatol Clin 2015, 11, 56-59.
6. Chuhjo T.; Nakao S.; Matsuda T. Successful treatment of persistent erythroid aplasia caused by Parvovirus B19 infection in a patient with common variable immunodeficiency with low-dose immunoglobulin. Am J Hematol 1999, 60, 222-224.